Acyclic Retinoid Inhibits Neointima Formation Through Retinoic Acid Receptor Beta-Induced Apoptosis
2007
Objectives— Acyclic
retinoid(
ACR) is a synthetic
retinoidwith a high safety profile that has been pursued with high expectations for therapeutic use in prevention (recurrence) and treatment of malignancies. With the objective of addressing the therapeutic potential in the cardiovasculature, namely
neointimaformation, effects of
ACRon
neointimaformation and the involved mechanisms were investigated. Methods and Results—
ACRwas administered to cuff-injured mice which showed inhibition of
neointimaformation. Investigation of involved mechanisms at the cellular and molecular levels showed that
ACRinduces apoptosis of neointimal cells and this to be mediated by selective induction of
retinoic-acid receptorβ (RARβ) which shows growth inhibitory and proapoptotic effects on smooth muscle cells. Conclusion— We show that
ACRinhibits
neointimaformation by inducing RARβ which in turn inhibits cell growth and induces apoptosis. The
retinoid,
ACR, may be potentially exploitable for treatment and prevention o...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
33
References
11
Citations
NaN
KQI